Youth justice in England and Wales

Shareholders of Abcam Approve Proposed Acquisition by Danaher

Retrieved on: 
Monday, November 6, 2023
Research, Finance, Genetics, Clinical Trials, Professional Services, Biotechnology, Health, Pharmaceutical, Science, Danaher, Youth justice in England and Wales, NYSE, High court, Court, Mass meeting, Acquisition, Transaction, Resolution, Extraordinary general meeting, Proxy, Danaher Corporation, DHR, England, Scheme, Management, Security (finance), Cryptocurrency, Abcam

Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, which entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation (NYSE: DHR) (‘Danaher’), today announced that its shareholders have approved the proposal for Danaher to acquire all of the outstanding shares of Abcam for $24.00 per share in cash (the ‘Transaction’).

Key Points: 
  • Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, which entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation (NYSE: DHR) (‘Danaher’), today announced that its shareholders have approved the proposal for Danaher to acquire all of the outstanding shares of Abcam for $24.00 per share in cash (the ‘Transaction’).
  • “With this approval, we are focused on moving swiftly toward transaction close and ensuring a successful transition to deliver maximum value to our shareholders, employees, and customers.”
    “We are thrilled shareholders have overwhelmingly approved the Transaction.
  • This outcome has arrived at the right time for Abcam to embark on the next chapter in its story within the Danaher family,” said Alan Hirzel, Chief Executive Officer of Abcam.
  • The Resolution was therefore passed by the requisite majority of Abcam Shareholders.

Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam

Retrieved on: 
Monday, October 23, 2023
Biotechnology, Health, Science, Pharmaceutical, Research, CREST, Glass Lewis, Danaher, BLUE, Sale, Citibank, Youth justice in England and Wales, High court, EBITDA, Court, Mass meeting, Acquisition, Annual general meeting, Glass, ISS, Scheme, Union councils of Jessore District, Management, Security (finance), Cryptocurrency, Auction, Abcam, Proxy, Equiniti

Abcam plc (Nasdaq: ABCM) (‘Abcam,’ the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, announced that leading independent proxy advisor, Glass Lewis, recommended that Abcam shareholders vote “FOR” Danaher Corporation’s (“Danaher” or “DHR”) proposed acquisition of Abcam (the “Transaction”) ahead of its shareholder meetings on November 6, 2023.

Key Points: 
  • Abcam plc (Nasdaq: ABCM) (‘Abcam,’ the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, announced that leading independent proxy advisor, Glass Lewis, recommended that Abcam shareholders vote “FOR” Danaher Corporation’s (“Danaher” or “DHR”) proposed acquisition of Abcam (the “Transaction”) ahead of its shareholder meetings on November 6, 2023.
  • Alan Hirzel, Chief Executive Officer of Abcam, said: “Following the publication of Glass Lewis’s recommendation on October 21, we’re pleased that both of the world’s leading proxy advisors support our board’s unanimous recommendation that shareholders vote ‘FOR’ the proposed sale to Danaher.
  • Based on these factors, and absent a superior competing offer, we believe the Scheme warrants shareholder support at this time.
  • As such, support for the proposed transaction is warranted.”
    The Board of Directors and management of Abcam recommend shareholders vote “FOR” Danaher’s proposed acquisition of Abcam.

Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam

Retrieved on: 
Tuesday, October 17, 2023
Biotechnology, Science, Health, Research, Institutional Shareholder Services, Mass meeting, Acquisition, Annual general meeting, BLUE, High court, Court, CREST, ISS, Citibank, Youth justice in England and Wales, Danaher, Sale, Management, Cryptocurrency, Security (finance), Auction, Equiniti, Proxy, Abcam

Abcam plc (Nasdaq: ABCM) (‘Abcam,’ the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today announced that leading independent proxy advisor Institutional Shareholder Services (‘ISS’), recommended that Abcam shareholders vote “FOR” Danaher Corporation’s (‘Danaher’ or ‘DHR’) proposed acquisition of Abcam (the ‘Transaction’) ahead of its shareholder meetings on November 6, 2023.

Key Points: 
  • Abcam plc (Nasdaq: ABCM) (‘Abcam,’ the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today announced that leading independent proxy advisor Institutional Shareholder Services (‘ISS’), recommended that Abcam shareholders vote “FOR” Danaher Corporation’s (‘Danaher’ or ‘DHR’) proposed acquisition of Abcam (the ‘Transaction’) ahead of its shareholder meetings on November 6, 2023.
  • Alan Hirzel, Chief Executive Officer of Abcam, said: “We are pleased that ISS supports our board’s unanimous recommendation that shareholders vote “FOR” the proposed sale to Danaher.
  • We are confident this transaction is in the best interests of Abcam and its shareholders, and will deliver an excellent outcome for Abcam’s employees and customers.
  • Other materials related to the upcoming Abcam shareholder vote, including Abcam’s investor presentation are available at https://corporate.abcam.com/investors/danaher-abcam/ .

Abcam Files and Mails Scheme Circular Seeking Approval of Acquisition of Abcam by Danaher for $24.00 per Share

Retrieved on: 
Thursday, October 5, 2023
Research, Technology, Medical Devices, Finance, Other Technology, Health Technology, Professional Services, Biotechnology, Health, Science, DHR, NYSE, Mass meeting, Acquisition, Morgan Stanley, Annual general meeting, Shareholder Meeting, Lazard, BLUE, High court, Court, Transaction, Proxy, CREST, Volume-weighted average price, Citibank, Sale, Youth justice in England and Wales, Volume, YELLOW, Cryptocurrency, Security (finance), Auction, Management, Equiniti, Abcam

Under the terms of the Transaction Agreement, Danaher will acquire all of the outstanding shares of Abcam for $24.00 per share in cash.

Key Points: 
  • Under the terms of the Transaction Agreement, Danaher will acquire all of the outstanding shares of Abcam for $24.00 per share in cash.
  • Highlights from the Scheme Circular include:
    The Transaction delivers significant, certain, and immediate value to shareholders.
  • Abcam received multiple bids to acquire the Company, rejected bids it deemed inadequate, and structured a process that induced bidders to increase offers.
  • Danaher’s $24.00 per share in cash offer was the highest and best price received at any point in the process.

Atento Achieves Key Milestone in its Restructuring, Receiving Backstop Commitments for 100% of its Exit Financing

Retrieved on: 
Tuesday, October 3, 2023
CRM, Growth, High court, Youth justice in England and Wales, England, Security (finance), Atento

Atento receives backstop commitments for an additional $76 million in exit financing.

Key Points: 
  • Atento receives backstop commitments for an additional $76 million in exit financing.
  • The exit financing, combined with the extinguishment of $663 million of liabilities pursuant to the Company's restructuring, will provide Atento with additional liquidity for future investment in the business.
  • The Company has successfully secured backstop commitments for 100% of the $76 million in exit financing required to execute its strategic turnaround conditional on the successful implementation of Atento's Restructuring Plan.
  • Atento embarked on this comprehensive restructuring plan with a clear vision to enhance its competitive edge, streamline operations and foster sustainable growth.

EQS-News: Adler Group S.A.: confirms today’s date as the Transaction Effective Date under its amended Notes

Retrieved on: 
Monday, April 17, 2023
Youth justice in England and Wales, High court, Part, England, Convention to propose amendments to the United States Constitution, AGPS, Transaction, Court, News, Security (finance), Note, English

Luxembourg, 17 April 2023 – Adler Group S.A. (“Adler Group”) announces that certain amendments to each series of the Notes (as defined below) issued by Adler Group and substituted by its wholly-owned English subsidiary, AGPS BondCo PLC (“AGPS”), have become effective as of today’s date (the “Transaction Effective Date”).

Key Points: 
  • Luxembourg, 17 April 2023 – Adler Group S.A. (“Adler Group”) announces that certain amendments to each series of the Notes (as defined below) issued by Adler Group and substituted by its wholly-owned English subsidiary, AGPS BondCo PLC (“AGPS”), have become effective as of today’s date (the “Transaction Effective Date”).
  • On 12 April 2023, the Court issued a sanction order approving the Proposed Amendments (the “Sanction Order”).
  • Following the Sanction Order and pursuant to the terms and conditions of each series of the Notes, Adler Group hereby confirms today’s date as the Transaction Effective Date (as defined in each series of the Notes), on which the Proposed Amendments to each series of the Notes have been unconditionally implemented.
  • 17.04.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.

EQS-News: Adler Group S.A. welcomes approval of restructuring plan under English law

Retrieved on: 
Saturday, April 15, 2023
News, Youth justice in England and Wales, Adler, Court of cassation, Bank statement, High court, Part, England, AGPS, Companies Act 2006, Security (finance)

Luxembourg, 12 April 2023 – Adler Group S.A. (“Adler Group”) welcomes the approval by the High Court of Justice of England and Wales of the restructuring plan under Part 26A of the Companies Act 2006 of AGPS BondCo PLC, a 100% subsidiary of Adler Group.

Key Points: 
  • Luxembourg, 12 April 2023 – Adler Group S.A. (“Adler Group”) welcomes the approval by the High Court of Justice of England and Wales of the restructuring plan under Part 26A of the Companies Act 2006 of AGPS BondCo PLC, a 100% subsidiary of Adler Group.
  • With the sanctioning, material requirements for the implementation of the amendments of the terms and conditions of the notes of AGPS BondCo PLC are being met and new money will be provided by a group of bondholders.
  • Chairman of the Board of Directors of Adler Group, Prof. Dr. A. Stefan Kirsten, says: “With the positive court decision of the High Court in London, we may now finally implement our restructuring plan.
  • 12.04.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.

JUSAN TECHNOLOGIES LIMITED BRINGS CLAIMS IN ENGLISH COURT TO CLEAR ITS NAME

Retrieved on: 
Friday, March 3, 2023
England, Transparency International, High Court of Singapore, Insurance, Youth justice in England and Wales, Conference proceedings, NIS, Telegraph Media Group, High court, SLAPP Suits, LLP, Defamation, Court, Publication, SLAPP, Family, Culture, Hostility, Investment, England and Wales, Republic, OD, JTL, Corruption Perceptions Index, Disasters Emergency Committee, Bureau, Ventilation, Bank statement, NU, Journalism, Nazarbayev University, TBIJ, Bureau of Investigative Journalism, Cryptocurrency

A UK business, Jusan Technologies Limited ("JTL") has commenced two defamation claims in the English Court, the first against The Bureau of Investigative Journalism ("TBIJ") and the Telegraph Media Group Limited ("TMGL"), and the second against openDemocracy Limited ("OD").

Key Points: 
  • A UK business, Jusan Technologies Limited ("JTL") has commenced two defamation claims in the English Court, the first against The Bureau of Investigative Journalism ("TBIJ") and the Telegraph Media Group Limited ("TMGL"), and the second against openDemocracy Limited ("OD").
  • JTL has commenced the following claims in the High Court of Justice of England and Wales:
    1.
  • OD also claims that JTL participated in a US$200 million transaction with a third party at a significant undervalue.
  • The cases are Jusan Technologies Ltd v The Bureau of Investigative Journalism and another, and Jusan Technologies Ltd v openDemocracy Ltd, case numbers QB-2022-002660 and QB-2022-002661, in the High Court of Justice of England and Wales.

Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc

Retrieved on: 
Sunday, January 8, 2023
Contingent value rights, Part, High Court, ADS, Priority review, Highbridge Capital Management, Transaction, England, Acquisition, Patient, Youth justice in England and Wales, CVR Partners, UK, Degenerative disease, CVR, FDA, Cooley LLP, Centerview Partners, Dechert, Eileen M. Decker, Bank, Real estate, Pharmaceutical industry, Car rental, Financial adviser, Chiesi Farmaceutici

The Transaction was unanimously approved by both Chiesi and Amryt Boards of Directors and is anticipated to close by the end of the first half of 2023, subject to the satisfaction of all closing conditions.

Key Points: 
  • The Transaction was unanimously approved by both Chiesi and Amryt Boards of Directors and is anticipated to close by the end of the first half of 2023, subject to the satisfaction of all closing conditions.
  • These accomplishments are a testament to the Amryt team’s commitment and passion for patients that are impacted by rare and orphan diseases.
  • Centerview Partners LLC is serving as exclusive financial advisor and Dechert LLP is serving as legal advisor to Chiesi.
  • Moelis & Company LLC is serving as exclusive financial advisor and Cooley LLP and Gibson Dunn & Crutcher LLP are serving as legal advisors to Amryt.

JUSAN TECHNOLOGIES LIMITED BRINGS CLAIMS IN ENGLISH COURT TO CLEAR ITS NAME

Retrieved on: 
Thursday, September 22, 2022
Income, TBIJ, JTL, Bureau of Investigative Journalism, Journalism, Transparency International, NU, High Court, Corruption, Compliance, Bureau, Youth justice in England and Wales, England, Corruption Perceptions Index, Investment, LLP, NIS, Nazarbayev University, Disasters Emergency Committee, Family, Insurance, OD, Mission statement, Private investigator, Online gambling, Medical device

JTL recently commenced the following claims in the High Court of Justice of England and Wales:

Key Points: 
  • JTL recently commenced the following claims in the High Court of Justice of England and Wales:
    1.
  • OD also claims that JTL participated in a US$200 million transaction with a third party at a significant undervalue.
  • JTL was not offered any opportunity prior to publication to verify the factual accuracy of and respond to the allegations.
  • Its main source of income and revenue comes from First Heartland Securities JSC, which owns First Heartland Jusan Bank JSC.